Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

European Medicines Group

This page shows the latest European Medicines Group news and features for those working in and with pharma, biotech and healthcare.

How to keep your name development on schedule after the recent EMA NRG announcement

How to keep your name development on schedule after the recent EMA NRG announcement

Three key action points. For those individuals and companies invited to attend the European Medicines Agency Name Review Group (EMA NRG) joint meetings, we are given the first chance to receive

Latest news

  • EMA geriatric expert group

    The European Medicines Agency has established an expert group to provide advice on issues related to the elderly as part of the agency's Committee for Medicinal Products for Human Use. ... The European Medicines Agency (EMA) has established an expert

  • New EMG leadership announced

    The European Medicines Group has elected Matthew Speers as chair and Steve Turley as vice chair. ... Matthew Speers has been elected chair of the European Medicines Group (EMG), which represents the UK voice of research-driven pharmaceutical companies

  • Ark files documentation on Cerepro

    Ark Therapeutics Group has filed documentation with the European Medicines Agency (EMA) in relation to its request for re-examination of the marketing approval application (MAA) for Cerepro, Ark's novel ... The European Committee for Medicinal Products

More from news
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • Shaping healthcare Shaping healthcare

    In February, when you were appointed vice-chair at the European Medicines Group, you said you were looking forward to ‘shaping’ the healthcare environment.

  • Sustainable solutions Sustainable solutions

    But, with Alex elected chair of UK industry group the European Medicines Group over the summer, he's increasingly been taking a multi-company view on the issue as the Group ... Representing European pharma in the UK. Set up in 2001, the European

More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Former Sanofi UK MD to head Teva UK Former Sanofi UK MD to head Teva UK

    Whilst in this position, he also served as Industry Chair of the Medicines Access Group (MAG), Chair of the European Medicines Group (EMG) and was a board member with the ABPI.

  • UCB CEO elected to the Ministerial Industry Strategy Group UCB CEO elected to the Ministerial Industry Strategy Group

    Jean-Christophe Tellier assumed the role of CEO on January 1. UCB's new CEO Jean-Christophe Tellier has been elected to join the Ministerial Industry Strategy Group (MISG). ... Tellier was elected by member of the European Medicines Group (EMG) and will

  • EMG appoints Merck and Boehringer directors as new officers EMG appoints Merck and Boehringer directors as new officers

    UK trade body the European Medicines Group (EMG) has elected David Garmon-Jones, UK managing director of Merck Sereno, as its new chair and Zinta Krumins, UK managing director of Boehringer ... Garmon-Jones (left) was previously vice chair at the

  • Lundbeck's Steve Turley re-elected as EMG chair Lundbeck's Steve Turley re-elected as EMG chair

    And Actelion's Robin Bhattacherjee retains vice-chair position. The European Medicines Group (EMG) has made several senior appointments, re-electing both Lundbeck's Steve Turley as chair and Actelion's ... Turley (pictured) was originally appointed chair

More from appointments
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Quick links

Infographics

Multimedia